443912-70-7

Basic information

• Product Name: 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-,methylester(9CI)
• Synonyms: 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-,methylester(9CI);4-Methyltetrahydropyran-4-carboxylic acid methyl ester;Tetrahydro-4-methyl-2H-pyran-4-carboxylic acid methyl ester;Methyl 4-Methyltetrahydro-2H-pyran-4-carboxylate;Methyl 4-Methyltetrahydro...;Methyl 4-Methyloxane-4-carboxylate;methyl tetrahydro-4-methyl-2H-pyran-4-carboxylate
• CAS NO: 443912-70-7
• Molecular Formula: C8H14O3
• Molecular Weight: 158.196
• Product Categories: CARBOXYLICESTER
• Mol File: 443912-70-7.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 195℃
• Flash Point: 72℃
• Appearance: /
• Density: 1.030
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-,methylester(9CI)(443912-70-7)
• EPA Substance Registry System: 2H-Pyran-4-carboxylicacid,tetrahydro-4-methyl-,methylester(9CI)(443912-70-7)

Safety Data

• Hazardous Substances Data: 443912-70-7(Hazardous Substances Data)

Usage

General Description

The chemical compound 2H-Pyran-4-carboxylicacid, tetrahydro-4-methyl-, methylester(9CI) is an organic ester derived from a group of chemicals known as pyrans. It contains a tetrahydro-4-methyl-2H-pyran-4-carboxylic acid backbone and a methyl ester functional group attached to the carboxylic acid moiety. Pyrans are a class of chemicals characterized by a six-membered ring structure containing five carbon atoms and one oxygen atom. The specific structure of this compound indicates that it has undergone a reduction process, as suggested by the prefix tetrahydro-, and has a methyl group on the fourth carbon position. The information available on this chemical compound does not provide details about its use or biological activity.

Upstream product

• 74-88-4 methyl iodide 
• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 

Downstream Products

• 1307304-94-4 C₁₆H₂₂N₂O₂ 
• 65626-22-4 4-methyltetrahydro-2H-pyran-4-carbaldehyde 
• 1338815-17-0 3-(4-methyltetrahydro-2H-pyran-4-yl)-1-(p-tolyl)-1H-pyrazol-5-amine 
• 1338814-68-8 2-methoxy-N-(4-(4-(3-(3-(4-methyltetrahydro-2H-pyran-4-yl)-1-p-tolyl-1H-pyrazol-5-yl)ureido)naphthalen-1-yloxy)pyridin-2-yl)acetamide 
• 233276-38-5 4-methyltetrahydro-2H-pyran-4-carboxylic acid 
• 502609-47-4 (4-methyltetrahydro-2H-pyran-4-yl)methanol 

Relevant articles and documents

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

Substituted Oxopyridine Derivatives and Use Thereof in the Treatment of Cardiovascular Disorders

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment o